

| Á¦¸ñ | [MFDS] ÀǾàǰµî ¼öÀÔ°ü¸® ±âÁØ ÁúÀÇÀÀ´äÁý | ||
|---|---|---|---|
| µî·ÏÀÏ | 2017-04-25 | Á¶È¸¼ö | 1,337 |
| ÷ºÎÆÄÀÏ | ÀǾàǰµî_¼öÀÔ°ü¸®_±âÁØ_ÁúÀÇÀÀ´äÁý_°Ô½Ã.pdf | ||
| ³»¿ë | ¾È³çÇϼ¼¿ä. ½Ä¾àó¿¡¼ ´ÙÀ½°ú °°ÀÌ ÀǾàǰµî¿¡ °üÇÑ ¼öÀÔ°ü¸® ±âÁØÀÇ ÁúÀÇÀÀ´äÁýÀ» Á¦Á¤ÇÏ¿´½À´Ï´Ù. ¦£ÀǾàǰ µîÀÇ ¾ÈÀü¿¡ °üÇÑ ±ÔÄ¢¦Ã [º°Ç¥6ÀÇ2] ÀǾàǰµî ¼öÀÔ°ü¸® ±âÁØ °ü·Ã, ÀǾàǰ ¹× ÀǾà¿Üǰ ¼öÀÔ¾÷ÀÚ°¡ ÀÚÁÖ Áú¹®ÇÏ´Â »çÇ×À» ¼³¸íÇÏ¿© ¼öÀÔ¾÷ÀÚ µîÀÇ ÀÌÇØ¸¦ µ½°íÀÚ 'ÀǾàǰµî ¼öÀÔ°ü¸® ±âÁØ ÁúÀÇÀÀ´äÁý'À» Á¦Á¤ÇÏ¿´½À´Ï´Ù. °¨»çÇÕ´Ï´Ù.
|
||
| ÀÌÀü±Û | [MFDS] ¡¸ÀǾàǰµ¿µî¼º½ÃÇè±âÁØ¡¹ ÀϺΰ³Á¤°í½Ã |
|---|
| ´ÙÀ½±Û | [EMA] MHRA's Interpretation of Cross Contamination & PDEs |
|---|